Regulation & Policy (Pharma & Healthcare)


Publication Single User License (PDF) Price
The Politics of Pharma - Washington, States and the Courts Impact on the Industry

The Politics of Pharma - Washington, States and the Courts Impact on the Industry

Date Published: Apr 15 2013

The Politics of Pharma - Washington, States and the Courts Impact on the Industry

Summary

Politics have a greater direct effect on the pharmaceutical industry than almost any other in the US, and correspondingly, pharma makes considerable investments in election campaigns. The November elections kept the face of Washington the same, with the re-election of President Obama, Democratic control of the Senate and Republican control of the House. However, the outcome of the elections will still impact the industry in a variety of ways.

$3,900.00
Electronic Medical Records Market to 2017

Electronic Medical Records Market to 2017 - Government Financial Incentives and Benefits in terms of Costs and Quality of Healthcare Drive Adoption among Physicians and Hospitals

Date Published: Mar 31 2012

Electronic Medical Records Market to 2017 - Government Financial Incentives and Benefits in terms of Costs and Quality of Healthcare Drive Adoption among Physicians and Hospitals

 

Summary

 
$3,500.00
Drug Recalls and Warning Letters

Drug Recalls and Warning Letters - Increasing Numbers Caused by Manufacturing Errors and Regulatory Non-compliance Issues

Date Published: May 7 2011

Drug Recalls and Warning Letters - Increasing Numbers Caused by Manufacturing Errors and Regulatory Non-compliance Issues

 

Summary

 
$3,500.00
Top 20 Contract Research Organizations (CRO)

Top 20 Contract Research Organizations (CRO) - Asia-Pacific, Especially India and China, Positioned to Benefit from Rising Financial and Regulatory Pressures in Western Pharmaceutical Markets

Date Published: Sep 1 2011
Top 20 Contract Research Organizations (CRO) - Asia-Pacific, Especially India and China, Positioned to Benefit from Rising Financial and Regulatory Pressures in Western Pharmaceutical Markets
 
Summary
 
$3,500.00
Emerging Pharmaceutical Market in South Africa to 2017

Emerging Pharmaceutical Market in South Africa to 2017 - Proposed Introduction of New Drug Regulatory Agency (SAHPRA) to Accelerate Drug Registration Process

Date Published: Jun 12 2012
GBI Research’s new report, “Emerging Pharmaceutical Market in South Africa to 2017 - Proposed Introduction of New Drug Regulatory Agency (SAHPRA) to Accelerate Drug Registration Process” provides in-depth analysis of the trends, issues and challenges in South Africa’s pharmaceutical market.
South African pharmaceutical market at $3.8 billion in 2011 and expects it to reach $7 billion in 2018.
 
$3,500.00
Pharmaceutical Pricing and Reimbursement - Adoption of Health Technology Assessments (HTA) Optimizes Drug Pricing and Accelerates Reimbursement Decision-Making

Pharmaceutical Pricing and Reimbursement - Adoption of Health Technology Assessments (HTA) Optimizes Drug Pricing and Accelerates Reimbursement Decision-Making

Date Published: Sep 1 2012
$3,500.00
Respiratory Disorders Therapeutics Market to 2017

Respiratory Disorders Therapeutics Market to 2017 - Novel Pipeline Molecules such as VX-770 and pirfenidone May Offset Negative Effect of Patent Expiries

Date Published: Sep 1 2011
$3,500.00
Global Pharmaceutical and Biotechnology Outlook 2014 :Rising Stars

Global Pharmaceutical and Biotechnology Outlook 2014 :Rising Stars

Date Published: Jan 14 2014
$2,500.00
Global Pharmaceutical & Biotechnology Outlook 2014: Mature Biotech

Global Pharmaceutical & Biotechnology Outlook 2014: Mature Biotech

Date Published: Jan 14 2014
$2,500.00
Global Pharmaceutical Survey 2012–2013: Market Trends, Marketing Spend and Sales Strategies in the Global Pharmaceutical Industry

Global Pharmaceutical Survey 2012–2013: Market Trends, Marketing Spend and Sales Strategies in the Global Pharmaceutical Industry

Date Published: Mar 9 2012

Synopsis

  • This report is the result of an extensive survey drawn from ICD Research’s exclusive panel of leading pharmaceutical industry executives. The opinions and forward looking statements of 247 industry executives have been captured in our in-depth survey.
  • The research is based on primary survey research conducted by ICD Research accessing its B2B panels comprised of senior marketing decision makers and leading supplier organizations.
$2,000.00
Global Pharmaceutical Survey 2012–2013: Market Trends, Buyer Spend and Procurement Strategies in the Global Pharmaceutical Industry

Global Pharmaceutical Survey 2012–2013: Market Trends, Buyer Spend and Procurement Strategies in the Global Pharmaceutical Industry

Date Published: Mar 9 2012

Synopsis

  • This report is the result of an extensive survey drawn from ICD Research’s exclusive panel of leading pharmaceutical industry executives. The opinions and forward looking statements of 247 industry executives have been captured in our in-depth survey.
  • The geographical scope of the research is global - drawing on the activity and expectations of leading industry players across the Americas, Europe, Asia-Pacific and Africa and Middle East.
$2,000.00
CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Vietnam

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Vietnam

Date Published: Jun 1 2014

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Vietnam

Summary

$1,995.00
CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Republic of China (Taiwan)

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Republic of China (Taiwan)

Date Published: Jun 1 2014

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Republic of China (Taiwan)

Summary

$1,995.00
CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - United Arab Emirates

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - United Arab Emirates

Date Published: Jul 14 2014

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - United Arab Emirates

Summary

$1,995.00
Healthcare, Regulatory and Reimbursement Landscape Indonesia

Healthcare, Regulatory and Reimbursement Landscape - Indonesia

Date Published: May 21 2012

Healthcare, Regulatory and Reimbursement Landscape - Indonesia

 

Summary

 
$1,995.00
Healthcare, Regulatory and Reimbursement Landscape - Australia

Healthcare, Regulatory and Reimbursement Landscape - Australia

Date Published: Jul 24 2012
 “Healthcare, Regulatory and Reimbursement Landscape Australia”. The report is an essential source of information and analysis on the healthcare, regulatory and reimbursement landscape in Australia. It identifies key trends, and most importantly, provides valuable insights into the trends and segmentation of the pharmaceutical and medical devices market. It is built using data and information sourced from proprietary databases, secondary research and in-house analysis by GlobalData’s team of industry experts.
$1,995.00
CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - South Korea

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - South Korea

Date Published: Mar 31 2014
$1,995.00
CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Indonesia

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Indonesia

Date Published: Apr 7 2014
The pharmaceutical market in Indonesia was worth approximately $3.1 billion in 2008 and is projected to reach approximately $17.6 billion by 2020.
$1,995.00
CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Malaysia

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Malaysia

Date Published: Apr 15 2014
Malaysia’s healthcare market is projected to reach approximately $3.7 billion by 2020 , at a Compound Annual Growth Rate (CAGR) of 9.5% (MOPI, 2014).
$1,995.00
China Pharmaceutical Guidebook

China Pharmaceutical Guidebook: Latest Chinese Regulations for Imported Drug Registration

Date Published: May 1 2011

China possesses a fourth population in the world and has one of the largest drug markets round the world. By 2006, sales on the Chinese drug market have reached $12 billion dollars, an increase of 3.8 fold over 1998 level. A series of factors, such as an increasingly ageing population, accelerating growth of urban population as well as expansion of healthcare covering urban and rural, will grow the Chinese drug market with a growth rate of 20-25 percent per annum in next five years. China is expected to become the fifth largest drug market in the world by 2010.

$1,495.00

Pages

Shopping cart

0 Items $0.00
Market Research Special Offers
Not able to find what you are looking for?
Call Us
WHY CHOOSE MARKET RESEARCH REPORTS?
1
Trusted By Leaders
2
Shop With Confidence
3
Customer Centric
4
Personalized Solutions
5
Secure Checkout

User login

Clients Who Trust Us

Orange, Google, Microsoft, Barclays, CassidianIntel, TPG, Elit Net, Cross Business Producers, AcmavolpakB. Braun, Cobham, fiserv, Harris, Wipro, AonAl Meera, Nomura Research Institute, Tata Consultancy Services, Amara Raja, Hiranandani EnergyMunich Re, Lotte Chemical, National Post, First Data